Avalon GloboCare (NASDAQ:CHGA – Get Free Report) and Microsoft (NASDAQ:MSFT – Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.
Volatility and Risk
Avalon GloboCare has a beta of -0.15, meaning that its share price is 115% less volatile than the S&P 500. Comparatively, Microsoft has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500.
Institutional & Insider Ownership
1.4% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 71.1% of Microsoft shares are owned by institutional investors. 16.8% of Avalon GloboCare shares are owned by company insiders. Comparatively, 0.0% of Microsoft shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Avalon GloboCare and Microsoft”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avalon GloboCare | $1.26 million | 0.73 | -$18.26 million | ($13.80) | -0.06 |
| Microsoft | $331.84 billion | 11.37 | $133.75 billion | $19.16 | 26.53 |
Microsoft has higher revenue and earnings than Avalon GloboCare. Avalon GloboCare is trading at a lower price-to-earnings ratio than Microsoft, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings for Avalon GloboCare and Microsoft, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avalon GloboCare | 1 | 0 | 0 | 0 | 1.00 |
| Microsoft | 0 | 4 | 46 | 1 | 2.94 |
Microsoft has a consensus target price of $612.48, indicating a potential upside of 20.50%. Given Microsoft’s stronger consensus rating and higher probable upside, analysts plainly believe Microsoft is more favorable than Avalon GloboCare.
Profitability
This table compares Avalon GloboCare and Microsoft’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avalon GloboCare | N/A | N/A | -53.69% |
| Microsoft | 41.17% | 31.28% | 18.55% |
Summary
Microsoft beats Avalon GloboCare on 14 of the 15 factors compared between the two stocks.
About Avalon GloboCare
Avalon GloboCare is a biotechnology and healthcare company whose activities have included developing cell-based therapies and precision diagnostic technologies. Its research has focused on applications in areas such as cancer and regenerative medicine. The company has worked on cell therapy approaches, including CAR-T and natural killer cell technologies, as well as diagnostic products and services. These activities have included research and development programs, rather than a broad portfolio of established therapies.
About Microsoft
Microsoft Corporation is a global technology company that develops software, cloud services, devices, and digital solutions for consumers, businesses, and public-sector organizations. Founded in 1975 by Bill Gates and Paul Allen, the company is headquartered in Redmond, Washington. Its products and services include the Windows operating system, Microsoft 365 productivity applications, Azure cloud computing, LinkedIn, GitHub, Surface devices, and Xbox gaming products and services. Microsoft also provides business software, cybersecurity tools, and artificial intelligence technologies.
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.
